Abstract
(Anaesthesia. 2020;75:1424–1427) (Anesth Analg. 2021. doi: 10.1213/ANE.0000000000005389. Epub ahead of print) While the US Food and Drug Administration has issued a warning about the neurodevelopmental effects of anesthetic drugs in the third trimester of pregnancy and children under the age of 3, no clinical study has evaluated long-term neurodevelopmental outcomes following prenatal exposure to anesthetics. Since anesthetic drugs cross the placenta and the brain is particularly vulnerable in the prenatal period, it is plausible that prenatal anesthetic exposure could lead to adverse neurodevelopmental effects. This study examined the effects of prenatal exposure to general anesthetic agents and neuropsychological and behavioral survey scores at age 10.
Submitted Version (
Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
